Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

Q&As

Dr Ashley H VanDercar
Q&As
Setting Boundaries Benefits Both Clinician and Patient
06/04/2022
Dr Ashley H VanDercar explains the benefit of setting clinical boundaries, what constitutes a "crossing" versus a "violation," and how practitioners can incorporate effective boundaries with their patients.  
Dr Ashley H VanDercar explains the benefit of setting clinical boundaries, what constitutes a "crossing" versus a "violation," and how practitioners can incorporate effective boundaries with their patients.  
Dr Ashley H VanDercar explains...
06/04/2022
Psych Congress Network
Shirikjian
Q&As
Anxiety Symptoms Unchanged, Acknowledgment Increased During COVID-19 Pandemic
06/03/2022
Lara Shirikjian, DO, answers questions about her session "Effective Strategies for Treating Modern Day Anxiety" that occurred today at Psych Congress Elevate in Las Vegas, Nevada.
Lara Shirikjian, DO, answers questions about her session "Effective Strategies for Treating Modern Day Anxiety" that occurred today at Psych Congress Elevate in Las Vegas, Nevada.
Lara Shirikjian, DO, answers...
06/03/2022
Psychiatry & Behavioral Health
Dr Katlyn Nemani.
Q&As
Risk of COVID-19 Infection, Mortality in Patients with Bipolar Disorder, SMI Varies Depending on Medications Prescribed
06/02/2022
Dr Katlyn Nemani examines the practical applications and further areas of research surrounding the use of second-generation antipsychotic medications and risk of COVID-19 infection in patients with bipolar disorder and other serious mental...
Dr Katlyn Nemani examines the practical applications and further areas of research surrounding the use of second-generation antipsychotic medications and risk of COVID-19 infection in patients with bipolar disorder and other serious mental...
Dr Katlyn Nemani examines the...
06/02/2022
Psych Congress Network

Advertisement

Dr Nemani
Q&As
Antipsychotic Use May Decrease Risk of COVID-19 in Patients With BD and SMI
05/20/2022
Dr Nemani discusses her study that found the use of second-generation antipsychotic medications was associated with a decreased risk of COVID-19 infection in patients with bipolar disorder.
Dr Nemani discusses her study that found the use of second-generation antipsychotic medications was associated with a decreased risk of COVID-19 infection in patients with bipolar disorder.
Dr Nemani discusses her study...
05/20/2022
Psych Congress Network
Christoph Abe and Mikael Landen ENIGMA
Q&As
Abnormal Frontocortical Thinning Observed in Patients With Bipolar Disorder
04/25/2022
In the conclusion of this Q&A, researchers discuss the unexpected outcomes and clinical implications of their study that examined structural brain changes over time in bipolar disorder.
In the conclusion of this Q&A, researchers discuss the unexpected outcomes and clinical implications of their study that examined structural brain changes over time in bipolar disorder.
In the conclusion of this Q&A,...
04/25/2022
Psych Congress Network
Christoph Abe
Q&As
Study Highlights Mania Prevention Importance in Bipolar Disorder Treatment
04/21/2022
Christophe Abé, PhD, shares insights on his study that examined structural brain changes over time in bipolar disorder using longitudinal MRI and clinical data and also highlighted the importance of mania prevention in treatment.
Christophe Abé, PhD, shares insights on his study that examined structural brain changes over time in bipolar disorder using longitudinal MRI and clinical data and also highlighted the importance of mania prevention in treatment.
Christophe Abé, PhD, shares...
04/21/2022
Psych Congress Network

Advertisement

Kapil Aedma, MD, FAPA,
Q&As
Bullying Associated With Depressive Symptoms in School-Going Adolescents
04/08/2022
Kapil Aedma, MD, FAPA, answers questions about his study on the association of bullying with depressive symptoms in school-going children and discusses key takeaways for the clinicians working with them.
Kapil Aedma, MD, FAPA, answers questions about his study on the association of bullying with depressive symptoms in school-going children and discusses key takeaways for the clinicians working with them.
Kapil Aedma, MD, FAPA, answers...
04/08/2022
Psych Congress Network
Hanadi Hamadi
Q&As
Less Than 8% of Medicare Beneficiaries Had Disruption in Care Due to COVID-19
03/18/2022
Hanadi (Hana) Hamadi, PhD, answers questions about her recent study that investigated telehealth use by Medicare beneficiaries during the COVID-19 pandemic.
Hanadi (Hana) Hamadi, PhD, answers questions about her recent study that investigated telehealth use by Medicare beneficiaries during the COVID-19 pandemic.
Hanadi (Hana) Hamadi, PhD,...
03/18/2022
Psych Congress Network
wilens
Q&As
Misconceptions, Treatment of Adult ADHD
11/04/2021
Timothy E. Wilens, MD, answers questions about his Psych Congress 2021 session titled “What’s New in Adult and Pediatric ADHD: A 2021 Psychopharmacology Update” that focus on adult ADHD.
Timothy E. Wilens, MD, answers questions about his Psych Congress 2021 session titled “What’s New in Adult and Pediatric ADHD: A 2021 Psychopharmacology Update” that focus on adult ADHD.
Timothy E. Wilens, MD, answers...
11/04/2021
Psych Congress Network

Advertisement

Wilens
Q&As
Support, Accommodation May Reduce Pediatric ADHD Severity
11/04/2021
Pediatric attention-deficient/hyperactivity disorder (ADHD) can be “largely reversed” with the proper support, accommodation, and treatment, says Timothy E. Wilens, MD.
Pediatric attention-deficient/hyperactivity disorder (ADHD) can be “largely reversed” with the proper support, accommodation, and treatment, says Timothy E. Wilens, MD.
Pediatric...
11/04/2021
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use